ARCHIVES

Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head.

This article is from The Cancer Letter archive.

Vol. 31 No. 32 | September 9, 2005

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Cancer Center, Cooperative Group Trials

April 27, 2007

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

February 29, 2008

Task Force: No Routine Mammograms Until 50

November 20, 2009

Supporters And A Critic Of Burzynski Comment

October 30, 1998

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

IOM Panel Considering NCI Approach To Research In Minorities, Underserved

June 19, 1998